Changchun High-Tech Industry Group is a Chinese biopharmaceutical group selling genetic-engineering medicines, vaccines, and traditional Chinese medicines.
Changchun High-Tech Industry (Group) began as a developer of high-tech industrial-zone infrastructure before repositioning itself as an enterprise group built around medical-science innovation and industrial investment. Its main business lines are biopharmaceuticals, which it treats as primary, and real-estate development, which it treats as supplementary. Its operating companies include GenSci, BCHT, Huakang Pharmaceutical, and High-tech Real Estate.
In biopharmaceuticals the group concentrates on genetic-engineering medicines, biological vaccines, and modern traditional Chinese medicine. Its development pipeline includes a freeze-dried human rabies vaccine grown in human diploid cells, an anti-tetanus toxin monoclonal antibody, and GenSci098, an antibody against the thyroid-stimulating hormone receptor. Other programmes include a long-acting recombinant follicle-stimulating hormone fusion protein and GS1-144, an oral NK3R antagonist for menopausal vasomotor symptoms.

Legend Biotech
Chengdu Kanghua Biological Products

Zhejiang Huahai
en.huahaipharm.com

Huisheng Biopharmaceutical
huishengpharm.com

Shanghai Kehua Bio-Engineering
skhb.com

Hansoh Pharmaceutical Group
hspharm.com

Harbin Gloria Pharmaceuticals
China Grand Pharmaceutical and Healthcare Holdings

Yantai Dongcheng Pharmaceutical Co
dcb-group.com

Beijing Whale Technology

3SBio

Sinovent
evopointbio.com

Gan & Lee Pharmaceuticals
ganlee.com

Huadong Medicine
eastchinapharm.com

Taibang Biologic Group
chinabiologic.com

The Chatterjee Group
Haohai Biological Technology
Yipinhong Pharmacy

Sino Biopharmaceutical

Essex Bio-Technology
Companies similar to Changchun High-Tech include Legend Biotech, Chengdu Kanghua Biological Products, Zhejiang Huahai and Huisheng Biopharmaceutical.
Changchun High-Tech was founded in 1993.
Changchun High-Tech's headquarters is located in Changchun, Jilin, CN.